Both in Pharmaceuticals
Merck & Co. vs Johnson & Johnson
Over the past year MRK returned +81.3% and JNJ returned +46.7%; their daily moves had a correlation of 0.48.
MRK +81.3% JNJ +46.7%Growth of $1, one year, split-adjusted
| Metric | MRK | JNJ |
|---|---|---|
| Price | $149.52 | $273.20 |
| Market cap | $368.89B | $657.68B |
| Today | +2.18% | −0.73% |
| 1 month | +4.0% | +5.6% |
| 6 months | +33.3% | +20.3% |
| Year to date | +42.0% | +32.0% |
| 1 year | +72.7% | +46.4% |
| Revenue growth (YoY) | +5.1% | +5.9% |
| Gross margin | 73.5% | 68.1% |
| Net margin | −8.0% | 0.8% |
| P/E (TTM) | 116.3× | 40.9× |
| Price / sales | 5.5× | 6.6× |
| Net cash | -$46.77B | -$27.42B |
| Dividend yield | 2.27% | 1.96% |
| Volatility (60d) | 36.0% | 23.4% |
| Short % of float | 1.1% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).